While RAD51 protein is highly expressed in all three PTEN-deficient shSCM-GBM lines (control), ≥83% of the RAD51 protein is reduced in shRAD51-GBM (RAD51-deficient) lines. The gene discussed is RAD51; the disease is glioblastoma.